LY4066708
/ Eli Lilly
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 01, 2025
A Single- and Multiple-Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY4066708 in Healthy Participants
(clinicaltrials.gov)
- P1 | N=104 | Recruiting | Sponsor: Eli Lilly and Company
New P1 trial • Oncology
1 to 1
Of
1
Go to page
1